Skip to main content
HLB INC. logo

HLB INC. — Investor Relations & Filings

Ticker · 028300 ISIN · KR7028300002 KO Manufacturing
Open in API
Filings indexed 553 across all filing types
Latest filing 2023-03-13 Proxy Solicitation & In…
Country KR South Korea
Listing KO 028300

About HLB INC.

https://www.hlb.global/

HLB INC. is a biopharmaceutical company focused on developing new global anti-cancer drugs. The company's core activities center on advancing a pipeline of novel therapeutics through its worldwide network, which includes subsidiaries like Elevar Therapeutics and Immunomic Therapeutics. In addition to its primary focus on oncology, HLB's affiliated companies are involved in other life science areas, such as developing and manufacturing in vitro diagnostic medical devices, peptide-based biomaterials, and quasi-drugs. The group also has operations in composite materials and shipbuilding, reflecting its diversified origins.

Recent filings

Filing Released Lang Actions
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy) and is a '정정신고' (Correction Report) for a previously filed proxy solicitation document. It contains detailed information regarding the upcoming Annual General Meeting (AGM), including director nominations, audit committee appointments, and voting procedures. This document is a formal proxy statement used to solicit shareholder votes for the AGM, which falls under the 'Proxy Solicitation & Information Statement' category.
2023-03-13 Korean
주주총회집중일개최사유신고
AGM Information Classification · 1% confidence The document is a formal regulatory filing submitted to the KRX (Korea Exchange) regarding the scheduling of a General Meeting of Shareholders on a 'concentrated date'. It explains the company's inability to avoid this date due to audit report timelines. Since it is a regulatory disclosure regarding meeting logistics rather than the meeting materials themselves, proxy statements, or voting results, it falls under the general regulatory filing category.
2023-03-13 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for HLB Co., Ltd. It details the meeting date, location, agenda items (such as financial statement approval, board appointments, and articles of incorporation changes), and voting procedures (including electronic voting). This document is a standard proxy statement/notice sent to shareholders to inform them of an upcoming meeting and solicit their votes, which fits the definition of a Proxy Solicitation & Information Statement.
2023-03-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (DART system) used to disclose insider trading or changes in share ownership by company directors and executives. This corresponds to the 'Director's Dealing' category.
2023-03-10 Korean
[기재정정]타법인주식및출자증권취득결정(자율공시)
M&A Activity Classification · 1% confidence The document is a regulatory filing from HLB regarding the acquisition of shares in another company (PSMC). It specifically details the terms of the acquisition, including payment schedules and the purpose of the investment. It is a formal disclosure of a corporate transaction (M&A activity) rather than a report publication announcement or a general regulatory notice. Given the specific nature of the acquisition of shares in another entity, it falls under M&A activity.
2023-03-10 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status of major shareholders (Jin Yang-gon and special related parties) in HLB Co., Ltd., including changes in shareholding and collateral agreements. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2023-03-07 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.